Perkiomenville, PA, United States of America

Hillary Joy Millar Quinn

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Pharmaceutica Nv. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hillary Joy Millar Quinn. Retrieved from https://idiyas.com/inventor/hillary-joy-millar-quinn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Hillary Joy Millar Quinn: Innovator in Cancer Treatment**

Introduction

Hillary Joy Millar Quinn is an esteemed inventor located in Perkiomenville, Pennsylvania, USA. She has made significant strides in the field of cancer treatment with her innovative approach that involves the use of PRMT5 inhibitors. Her work showcases the potential of targeted therapies in addressing complex medical challenges.

Latest Patents

Quinn holds a patent for the invention titled "Methods of treating cancer using PRMT5 inhibitors." This patent provides novel methods for treating human patients diagnosed with cancer by administering a therapeutically effective amount of a PRMT5 inhibitor. The patent outlines specific methods that include administering initial doses at least about 0.1 mg per day for periods ranging from 5 to 21 days, followed by subsequent dosing periods of the same dosage, carefully spaced to optimize efficacy and patient outcomes.

Career Highlights

Hillary Quinn's affiliation with Janssen Pharmaceutica NV underscores her commitment to advancing pharmaceutical innovations. Her role at such a reputable organization highlights her expertise and the impact of her research in developing effective treatment strategies for cancer patients. Quinn's work is pivotal in making strides toward improving cancer therapies, thereby enhancing patient care and treatment possibilities.

Collaborations

Throughout her career, Quinn has collaborated with notable professionals, including Kathryn Elizabeth Packman and Nahor Haddish-Berhane. These partnerships foster a collaborative environment that is essential for scientific discovery and innovation in the pharmaceutical sciences. Together, they contribute to a research culture focused on breakthroughs in cancer treatment.

Conclusion

Hillary Joy Millar Quinn stands out as a significant figure in the realm of medical innovation, particularly in the fight against cancer. Her patent on PRMT5 inhibitors represents a crucial development in therapeutic methods for cancer treatment. As cancer research continues to evolve, Quinn's contributions will undoubtedly lead to new hope for patients and advancements in the medical field. Her work exemplifies the role of inventors in transforming scientific ideas into life-saving solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…